Feb 3, 2025 | Cancer Center News
Metastatic breast cancer, particularly estrogen receptor (ER) positive liver metastases, typically lacks a positive prognosis, quality of life, or effective treatment. But a new option now arises, with promising results. Zeynep Madak-Erdogan, the Associate Director...
Dec 10, 2024 | Cancer Center News
Read time: 2 minutesKeywords: testicular cancer, therapy, drug targets Testicular cancer is the most common cancer in young males ages 15 to 35. The most conventional chemotherapy drug used to treat this is called cisplatin, but it is toxic and comes with many...
Dec 4, 2024 | Cancer Center News
Read time: 2 minutesKeywords: cancer, cancer research Researchers at the Cancer Center at Illinois (CCIL) have made significant progress in the fight against cancer this year. Our scientists’ work is changing the future of cancer detection, diagnostics, and...
Dec 3, 2024 | Cancer Center News
Cancer Center at Illinois (CCIL) member Hee-Sun Han has developed an Intracellular Spatial Transcriptomic Analysis Toolkit (InSTAnT) that allows researchers to look at subcellular patterns. The research findings are published in Nature Communications. After intensive...
Nov 18, 2024 | Cancer Center News, Member Spotlight
The Cancer Center at Illinois (CCIL) welcomes their newest research member Diana Ranoa, who recently began a new Illinois faculty position as an Assistant Professor of Biochemistry in the School of Molecular & Cell Biology. Ranoa grew up in the Philippines, which...
Aug 12, 2024 | Cancer Center News
More than 4,000 miles, nearly two dozen states, and 11 weeks later, the 2024 Illini 4000 team has raised over $60,000 and arrived at the end of a long but fulfilling journey: a bike ride across America to fight cancer. The Illini 4000 is a non-profit organization...
